Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229373807> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4229373807 endingPage "S143" @default.
- W4229373807 startingPage "S142" @default.
- W4229373807 abstract "ABSTRACT Introduction The endocrine disease frequently interrupts sexual function, and sexual dysfunction may signal serious endocrine disease. Recent studies have claimed an association with hypothyroidism, low testosterone (T) levels and erectile dysfunction (ED), but causality is unclear. There is no study on the experimental model of hypothyroidism that was induced in rats by administration of propylthiouracil (PTU). Objective The purpose of this study was to investigate the deleterious effects of PTU-induced hypothyroidism on ED and T levels. In addition, Levothyroxine is known worldwide as the most common and least effective drug for controlling hypothyroidism. Methods Adult Sprague-Dawley rats (n = 35) were divided into five groups; control, PTU-induced hypothyroidism, PTU+ Levothyroxine, PTU+ Sustanon (a mixture of 4 types of T: propionate, phenylpropionate, isocaproate, decanoate) and PTU+ Levothyroxine + Sustanon. PTU was given in drinking water (0.05%) for 6 weeks. 4 weeks after the beginning of PTU treatment, Levothyroxine (20 mg/kg/day, oral) and Sustanon (10 mg/kg, I.M., once/week) were given for 2 weeks. Serum levels of total T, triiodothyronine (T3) and thyroxine (T4) were determined. The ratio of intracavernosal pressure (ICP) to mean arterial pressure (MAP) and total ICP were measured by cavernous nerve stimulation. The relaxant and contractile responses were evaluated on in vitro preparations of corpus cavernosum (CC) strips. The expression and localization of neuronal (nNOS), endothelial NOS (eNOS) and phosphodiesterase type 5 (PDE5) were determined using Western blotting and immunohistochemistry. The relative area of smooth muscle to collagen was measured using Masson trichrome staining. Results The rat model of hypothyroidism showed a significant decline in serum levels of total T, T3 and T4. Levothyroxine increased T3 and T4 levels while Sustanon normalized only total T levels. In addition, combined treatment of Levothyroxine and Sustanon enhanced all hormone levels. Rats with hypothyroidism displayed the lowest ICP/MAP ratio and total ICP for 7.5 V (P < .001 vs controls). Combined treatment returned reduced ICP/MAP and total ICP responses, while partial amelioration was observed after Levothyroxine and Sustanon treatment alone. In vitro endothelium-dependent acetylcholine-caused relaxation at 1 nM (P < .001 vs controls), electrical field stimulation-induced relaxant response at 20 Hz (P < .001 vs controls) and sildenafil-induced relaxation at 10 µM (P < .05 vs controls) were decreased in the CC strips from hypothyroid rats. The treatment with Levothyroxine and Sustanon increased the reduction in relaxation responses. Decreased in the expressions of eNOS and nNOS and increased in the expressions of PDE5 in the hypothyroid group were restored by Levothyroxine and Sustanon. Mono-treatment partially enhanced reduced smooth muscle mass while combined therapy completely recovered. Conclusions These results show that hypothyroidism adversely affects T levels and erectile responses via decreasing neurogenic and endothelium-dependent relaxation responses which were reversed by the combination therapy with Levothyroxine and Sustanon. Even though the associated alterations in T levels, ED and its reversibility indicate an exact role of thyroid hormones in the erection physiology. Disclosure Work supported by industry: no." @default.
- W4229373807 created "2022-05-10" @default.
- W4229373807 creator A5013759531 @default.
- W4229373807 creator A5020844161 @default.
- W4229373807 creator A5036588525 @default.
- W4229373807 creator A5041577160 @default.
- W4229373807 creator A5063355650 @default.
- W4229373807 creator A5072348280 @default.
- W4229373807 creator A5082032220 @default.
- W4229373807 creator A5084457457 @default.
- W4229373807 date "2022-05-01" @default.
- W4229373807 modified "2023-10-15" @default.
- W4229373807 title "045 Treatment with Levothyroxine and Testosterone Ameliorated Erectile Dysfunction in a Rat Model of Propylthiouracil-Induced Hypothyroidism" @default.
- W4229373807 doi "https://doi.org/10.1016/j.jsxm.2022.03.579" @default.
- W4229373807 hasPublicationYear "2022" @default.
- W4229373807 type Work @default.
- W4229373807 citedByCount "0" @default.
- W4229373807 crossrefType "journal-article" @default.
- W4229373807 hasAuthorship W4229373807A5013759531 @default.
- W4229373807 hasAuthorship W4229373807A5020844161 @default.
- W4229373807 hasAuthorship W4229373807A5036588525 @default.
- W4229373807 hasAuthorship W4229373807A5041577160 @default.
- W4229373807 hasAuthorship W4229373807A5063355650 @default.
- W4229373807 hasAuthorship W4229373807A5072348280 @default.
- W4229373807 hasAuthorship W4229373807A5082032220 @default.
- W4229373807 hasAuthorship W4229373807A5084457457 @default.
- W4229373807 hasConcept C126322002 @default.
- W4229373807 hasConcept C134018914 @default.
- W4229373807 hasConcept C2775883008 @default.
- W4229373807 hasConcept C2775960720 @default.
- W4229373807 hasConcept C2777911890 @default.
- W4229373807 hasConcept C2779279991 @default.
- W4229373807 hasConcept C2779929075 @default.
- W4229373807 hasConcept C2781115071 @default.
- W4229373807 hasConcept C71315377 @default.
- W4229373807 hasConcept C71924100 @default.
- W4229373807 hasConceptScore W4229373807C126322002 @default.
- W4229373807 hasConceptScore W4229373807C134018914 @default.
- W4229373807 hasConceptScore W4229373807C2775883008 @default.
- W4229373807 hasConceptScore W4229373807C2775960720 @default.
- W4229373807 hasConceptScore W4229373807C2777911890 @default.
- W4229373807 hasConceptScore W4229373807C2779279991 @default.
- W4229373807 hasConceptScore W4229373807C2779929075 @default.
- W4229373807 hasConceptScore W4229373807C2781115071 @default.
- W4229373807 hasConceptScore W4229373807C71315377 @default.
- W4229373807 hasConceptScore W4229373807C71924100 @default.
- W4229373807 hasIssue "Supplement_2" @default.
- W4229373807 hasLocation W42293738071 @default.
- W4229373807 hasOpenAccess W4229373807 @default.
- W4229373807 hasPrimaryLocation W42293738071 @default.
- W4229373807 hasRelatedWork W1977970588 @default.
- W4229373807 hasRelatedWork W1992438146 @default.
- W4229373807 hasRelatedWork W2001381637 @default.
- W4229373807 hasRelatedWork W2014764273 @default.
- W4229373807 hasRelatedWork W2022659954 @default.
- W4229373807 hasRelatedWork W2033141413 @default.
- W4229373807 hasRelatedWork W2101146068 @default.
- W4229373807 hasRelatedWork W2142667461 @default.
- W4229373807 hasRelatedWork W2146554192 @default.
- W4229373807 hasRelatedWork W2611776224 @default.
- W4229373807 hasVolume "19" @default.
- W4229373807 isParatext "false" @default.
- W4229373807 isRetracted "false" @default.
- W4229373807 workType "article" @default.